The Role of RMPs in Early-Phase Clinical Studies: Design and Implementation
The Role of RMPs in Early-Phase Clinical Studies: Design and Implementation Implementing Risk Management Plans in Early-Phase Clinical Studies Early-phase clinical trials, particularly Phase 1 and 2 studies, are critical for gathering first-in-human data and establishing a drug’s preliminary safety profile. Although these trials are often short in duration and involve a small number of…
Read More “The Role of RMPs in Early-Phase Clinical Studies: Design and Implementation” »